Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 02 Apr 2026 for Allogene Therapeutics, Inc., €6,193.
Filing timeline
BuySaleBenjamin Machinas Beneski
Insider track record
Disclosed buys
0
Disclosed sells
6
Signal history
Benjamin Machinas Beneski: trading record in brief
Benjamin Machinas Beneski is a declared insider of Allogene Therapeutics, Inc., with filings sourced from SEC (Form 4). In total, 7 filings cover trades dated from 1 March 2025 to 31 March 2026.
Every open-market trade on record is a sale: 6 sales worth €54k. The rest of the record consists of 1 share grant. Since January 2026: no purchases and 4 sales on the market.
The record was last updated on 2 April 2026 with an open-market sale (€6,193) in Allogene Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Benjamin Machinas Beneski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
2,867 shares@ US$2.5038.3% of flowCommon StockSEC:0002057918-26-000007:0
4,835 shares@ US$2.4727.4% of flowCommon StockSEC:0001737287-26-000015:0
7,132 shares@ US$2.6041.4% of flowCommon StockSEC:0002057918-26-000003:0
7,549 shares@ US$1.7329.0% of flowCommon StockSEC:0001737287-26-000011:0
786 shares@ US$1.222.2% of flowCommon StockSEC:0001737287-25-000094:0
5,488 shares@ US$1.97561.7% of flowCommon StockSEC:0001737287-25-000040:0
31,755 shares0Common StockSEC:0001737287-25-000026:0
7 of 7 declarations
